Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux

• Main Authors: Michelle Lightfoot (Author), Aylin N. Bilgutay (Author), Noah Tollin (Author), Scott Eisenberg (Author), Jake Weiser (Author), Leah Bryan (Author), Edwin Smith (Author), James Elmore (Author), Hal Scherz (Author), Andrew J. Kirsch (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection...